Patient guide • SI Medical Weight Loss
Understanding
Retatrutide
Clear information for your next conversation.
Curious about retatrutide for weight loss? Learn what is being studied, what remains uncertain, and which questions to bring to your healthcare provider.
Discuss Your Weight Loss OptionsCurrent status
Investigational medicine.
Research in progress.
Not FDA approved. Retatrutide remains under investigation.*
A local place to talk through your weight-management questions.
Start with the basics
What is retatrutide?
Retatrutide is an investigational medicine being developed by Lilly. It targets three hormone receptors: GIP, GLP-1, and glucagon. Researchers are studying its effects on weight and metabolic health.
* “Triple agonist” refers to three receptor targets, not three times the benefit. Retatrutide is investigational and is not approved for routine treatment. Study findings are not personal treatment recommendations or guaranteed outcomes.
Put the headlines in context
Research is a starting point.
Your care is personal.
Explore who took part in the research, what was measured, and how safety was monitored.*
01
What has been studied?
Trials have examined retatrutide in adults with obesity or overweight. The TRIUMPH-1 study record describes the study design, eligibility criteria, and outcomes.
02
What about side effects?
In the published Phase 2 trial, gastrointestinal side effects were the most common adverse events. Investigators also observed increases in heart rate.*
03
What remains uncertain?
* Research and regulatory review are ongoing. These findings are not a complete safety profile and do not establish an approved dose or an individual treatment recommendation.
Availability & safety
Understand access.
Bring your questions.
Ask your healthcare provider about the research, the exact medicine being discussed, and the weight-management options appropriate for your care.*
* The FDA warns against retatrutide sold to consumers for “research purposes” or “not for human consumption”: quality is unknown and it may be harmful. FDA also states that retatrutide cannot be used in compounding under federal law. An online price or vial label does not establish approval or legitimate access.
Questions worth asking
What is the exact product and its current approval status?
What evidence applies to my medical history?
What are the risks, alternatives, and follow-up needs?
If a clinical trial interests me, who can explain its eligibility and consent process?
Your next step at SI Medical
A plan built around you.
You do not need to choose a medication before your first conversation. At our family-owned clinics in Marion and Belleville, a medical weight loss appointment starts with your history, your goals, and your questions.
Our program includes consultation and examination, body composition assessment, nutrition and activity guidance, monthly follow-ups, and transition and maintenance support. Your provider can discuss treatment options appropriate for your individual needs.
Make your visit useful
Bring your medication and supplement list, relevant health history, and notes about previous weight loss efforts. Share what matters most to you, including tolerability, follow-up support, and cost.
For current program pricing, visit our pricing page. Confirm the exact recommended treatment and what your plan includes with the clinic.
Schedule a Weight Loss AppointmentYour questions, answered
Clarity before
the next step.
Use this guide to prepare for a conversation with a healthcare professional. Your own medical history deserves individual attention.
Is retatrutide the same as semaglutide or tirzepatide?
No. These are different medicines. Retatrutide is being investigated as a triple-receptor agonist and should not be treated as interchangeable with another prescription.
Is “GLP-3” another name for retatrutide?
You may see that nickname online. Lilly explains that it is not a scientific classification. “Triple agonist” describes retatrutide’s receptor targets more accurately.
Can I use this page as dosing guidance?
No. Study protocols are research documents, not instructions for self-treatment. This guide does not provide a dosing schedule or instructions for obtaining retatrutide.
Does this page mean SI Medical offers retatrutide?
This is an educational resource, not confirmation of availability or a prescription offer. Contact the clinic to discuss your current care options and the exact treatment being recommended.
Can I discuss weight loss options now?
Yes. Call SI Medical to arrange a medical weight loss appointment in Marion or Belleville and discuss your goals and next steps.*
Care close to home
Talk with a local team.
Choose the clinic that works for you and call to schedule a medical weight loss appointment.
Keep the information in context
Sources & further reading
* This is an educational research guide, not confirmation that SI Medical offers retatrutide, an instruction for self-treatment, or a promise of a prescription. Research and regulatory status can change. Individual medical advice and treatment decisions require your healthcare provider.
FDA: Retatrutide and unapproved weight loss products
Lilly: What to know about retatrutide
Start with a conversation
Your questions belong
in your care plan.
Talk with SI Medical about your goals and the weight-management options that may fit your needs.
Medical evaluation required. Treatment recommendations are individual.
